Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 09/Jul 18:28
Non Alcoholic Fatty Liver Disease Pipeline 2024 | Guangdong Raynovent Biotech, Dr. Falk Pharma GmbH, Enyo Pharma, Viking Therapeutics, Sagimet Biosciences, Terns, Sinew Pharma, Madrigal Pharmaceutical
DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease
Articles similaires
New drug shows promise in treating liver disease
Liver disease is a common condition affecting millions of adults in the United States. One serious form of this disease is nonalcoholic fatty liver...
Adenoid Cystic Carcinoma Market to Grow at a Substantial Growth Rate During the Forecast Period | HLB, Ayala Pharma, Merck, Amgen, CureVac, Actuate Therapeutics
Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...
Cutaneous T-Cell Lymphoma (CTCL) Emerging and Marketed Drugs Assessment | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, Key Companies | Medivir, 4SC
Cutaneous T-Cell Lymphoma (CTCL) Emerging and Marketed Drugs Assessment According to DelveInsight’s evaluation, globally, more than 25 key...
Vimgreen Pharma completes enrollment in phase 2 trial of VG081821AC to treat Parkinson's disease
Vimgreen Pharmaceuticals, a science─driven pharmaceutical company focused on the modulation of adenosine signalling, announced the completion of...
Stretching and Meditation: A Magical Remedy for Nighttime Muscle Cramps in Liver Disease
Highlights: People with cirrhosis (a chronic liver disease) experience muscle cramps at night (nocturnal muscle
New Definition of Steatotic Liver Disease Improves Prediction of Kidney Disease
TUESDAY, Aug. 20, 2024 -- Using a new classification of steatotic liver disease (SLD) based on the presence of metabolic dysfunction and alcohol...
Yeh Rishta Kya Kehlata Hai Actor Mohsin Khan Suffered Heart Attack At 32, Reveals 'Fatty Liver Ho Gaya Tha...'
Mohsin Khan recently shared shocking updates about his health.
Les derniers communiqués
-
Aucun élément